Bénédicte Ballanger

Years Active: 2021-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Chloé Laurencin, Sophie Lancelot, Inès Merida, Nicolas Costes, Jérôme Redouté, Didier Le Bars, Philippe Boulinguez, Bénédicte Ballanger
Distribution of α 2 -Adrenergic Receptors in the Living Human Brain Using [ 11 C]yohimbine PET. Biomolecules 13 (5) (2023)
Chloé Laurencin, Sophie Lancelot, Sarah Brosse, Inés Mérida, Jérôme Redouté, Elise Greusard, Ludovic Lamberet, Véronique Liotier, Didier Le Bars, Nicolas Costes, Stéphane Thobois, Philippe Boulinguez, Bénédicte Ballanger
Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study. Brain : a journal of neurology (2023)
Marion Criaud, Chloé Laurencin, Alice Poisson, Elise Météreau, Jérôme Redouté, Stéphane Thobois, Philippe Boulinguez, Bénédicte Ballanger
Noradrenaline and Movement Initiation Disorders in Parkinson's Disease: A Pharmacological Functional MRI Study with Clonidine. Cells 11 (17) (2022)
Marion Criaud, Jean-Luc Anton, Bruno Nazarian, Marieke Longcamp, Elise Metereau, Philippe Boulinguez, Bénédicte Ballanger
The Human Basal Ganglia Mediate the Interplay between Reactive and Proactive Control of Response through Both Motor Inhibition and Sensory Modulation. Brain sciences 11 (5) (2021)

Bénédicte Ballanger.css-eqlu8i{font-size:small;padding-left:4px;}